Changing – Page 2

Biopharma Layoff Trends in Q1 2025 and Outlook for Q2

4 months ago talkbio0Tagged Biopharma, Biopharma layoffs, Changing, Industry, Legal patent, Pharma, pharmaceutical employment, Q1 2025, Q2 layoff, regulatory, restructuring

Biopharma layoffs, Q1 2025 layoffs, biotech job cuts, pharma workforce reductions, restructuring, patent cliffs, regulatory challenges, Q2 layoff forecast, pharmaceutical employment trends, biopharma industry changes.

Mass Firings at FDA Spark Concerns Over Agency’s Future

5 months ago talkbio0Tagged Administration occupational activities, Changing, Drug Regulations, Leadership, public health medicine (field), Transplant Registry Unified Management Program, United States Food and Drug Administration

FDA, layoffs, leadership changes, public health, drug regulation, Trump administration

Sutro discards CEO, 50% of staff, sole clinical-stage ADC and manufacturing site to save cash

5 months ago talkbio0Tagged Cash, CEO, Changing, Sutro, therapeutic autologous dendritic cells

Sutro, therapeutic autologous dendritic cells, Changing, CEO, Cash

Makary Sails Through Senate Confirmation Hearing for FDA Commissioner

6 months ago talkbio0Tagged Advisory Committees, Changing, Confirmation, drug reviews, Makary, Martin, Senate, United States Food and Drug Administration, Vaccines

Martin Makary, FDA, Senate confirmation hearing, vaccine advisory committee, drug reviews, ethics, staffing changes

Drug Pricing and the Uncertain Future of the IRA Under Trump

6 months ago talkbio0Tagged Changing, drug price, IRA, Mediation, Medicare, Prices, repeal, Transplant Registry Unified Management Program, Uncertainty

IRA, Transplant Registry Unified Management Program, drug price, Medicare, Mediation, repeal, Changing, Uncertainty, Prices

Leadership Changes at Agios and Moderna: Board Resignation and New Marketing Chief

6 months ago talkbio0Tagged Agios, Board Resignation, Changing, Chief, David Schenkein, Drug Industry, Leadership, Mahery, marketing officer, Moderna

David Schenkein, Agios Pharmaceuticals, board resignation, Moderna, Amy Mahery, chief marketing officer, pharmaceutical industry, leadership changes

Kathy High Takes Helm at GV, ARCH-Backed Eye Disease Biotech RhyGaze; Arvinas Sees Leadership Shift

7 months ago talkbio0Tagged Arch of foot, Arvinas, Changing, Granulovirus, GV, Kathy, Leadership, RhyGaze

Kathy High, RhyGaze, GV, ARCH, eye disease biotech, Arvinas, leadership changes

RyCarma Therapeutics Unveils New Leadership and Company Name, Expands Focus on Heart Failure Treatment

7 months ago talkbio0Tagged ARMGO, biotech company, Cardiovascular Diseases, Changing, Heart failure, Leadership, Pharma, Rycals, RyCarma, skeletal muscle diseases

RyCarma Therapeutics, ARMGO Pharma, ryanodine receptor, Rycals, heart failure, cardiovascular diseases, skeletal muscle diseases, biotech company, new leadership, company name change.